He Junli

Reported to SECin USFilings at 1 company

No score on this page, by design. These filings come from the American register (SEC). We show them as facts, with what the share price did since each filing and since each trade; our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings by this filer, out of 8. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are this filer’s key figures and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first. Reported is the day the filing reached the regulator, usually a few days after the trade itself.

5 of 8
Reported insider transactions
CompanyTypeValueReportedCompanyValueTypeSharesReported
Harvard Apparatus Regenerative Technology, Inc.CEOConversion—202,533 sharesSep 25, 2026Harvard Apparatus Regenerative Technology, Inc.CEO—Conversion · Sep 25Conversion202,533Sep 25, 2026
Harvard Apparatus Regenerative Technology, Inc.CEOConversion—205,378 sharesSep 25, 2026Harvard Apparatus Regenerative Technology, Inc.CEO—Conversion · Sep 25Conversion205,378Sep 25, 2026
Harvard Apparatus Regenerative Technology, Inc.CEOConversion—310,000 sharesSep 25, 2026Harvard Apparatus Regenerative Technology, Inc.CEO—Conversion · Sep 25Conversion310,000Sep 25, 2026
Harvard Apparatus Regenerative Technology, Inc.CEOOpen-market buy$14,4596,725 sharesSep 25, 2026Harvard Apparatus Regenerative Technology, Inc.CEO$14,459Buy · Sep 25Open-market buy6,725Sep 25, 2026
Harvard Apparatus Regenerative Technology, Inc.CEOOpen-market buy$380,000361,905 sharesSep 25, 2026Harvard Apparatus Regenerative Technology, Inc.CEO$380,000Buy · Sep 25Open-market buy361,905Sep 25, 2026